Aker BioMarine and Lindsay Goldberg to form 50/50 joint venture

An affiliate of Lindsay Goldberg LLC ("LG" or "Lindsay Goldberg") - a New

York-based private investment firm with approximately USD 10 billion of equity

capital under management and a long-term investment horizon of up to 20 years -

has entered into an agreement with Aker BioMarine ASA ("AKBM" or "Aker

BioMarine") to acquire 50% of all outstanding shares in a newly established

joint venture company ("NewCo") that will own Trygg Pharma AS and Natural

Nutrition Development Ltd AS ("NND"), both wholly owned subsidiaries of Aker

BioMarine. Lindsay Goldberg will pay up to NOK 280 million for the 50% stake in

NewCo, of which NOK 140 million is paid upfront and another NOK 140 million is

subject to certain development milestones.

Please see attached.

For further information regarding Trygg Pharma, please contact:

Egil Bodd, Chairman of the board, Trygg Pharma, tel.: +47 900 20 341

Aaron Kramer, CEO, Trygg Pharma, tel.: +47 916 30 130

For further information regarding Aker BioMarine, please contact:

Fredrik Nygaard, CFO and IR contact, Aker BioMarine, tel.: +47 24 13 00 00

[HUG#1442502]

AI assistant